The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Amgen

Optimized economic evaluation for the United States (US) of nab-paclitaxel plus gemcitabine (NAB-P+GEM), FOLFIRINOX (FFX), and gemcitabine (GEM) as first-line treatment for metastatic pancreatic cancer (mPDA).
 
Mahdi Gharaibeh
No Relationships to Disclose
 
Ali McBride
Honoraria - Hospira
Consulting or Advisory Role - Janssen
 
J. Lyle Bootman
No Relationships to Disclose
 
Hitendra Patel
No Relationships to Disclose
 
Ivo Abraham
No Relationships to Disclose